- Adweek, Wednesday, September 5, 2012 10:45 AM
After Excedrin products were pulled from shelves last January
due to manufacturing problems, parent Novartis says the date for re-release has been pushed to the fourth quarter of 2012. In the meantime, several of Johnson & Johnson’s Tylenol products
are still in short supply after three years of voluntary recalls.
Read the whole story at Adweek »